CA2065287A1 - Isolats hvc nouveaux - Google Patents

Isolats hvc nouveaux

Info

Publication number
CA2065287A1
CA2065287A1 CA2065287A CA2065287A CA2065287A1 CA 2065287 A1 CA2065287 A1 CA 2065287A1 CA 2065287 A CA2065287 A CA 2065287A CA 2065287 A CA2065287 A CA 2065287A CA 2065287 A1 CA2065287 A1 CA 2065287A1
Authority
CA
Canada
Prior art keywords
new
hcv isolates
new hcv
isolates
hcv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2065287A
Other languages
English (en)
Other versions
CA2065287C (fr
Inventor
Tatsuo Miyamura
Izumu Saito
Michael Houghton
Amy J. Weiner
Jang Han
Janice A. Kolberg
Tai-An Cha
Bruce Duncan Irvine
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DIRECTOR GENERAL OF NATIONAL INSTITUTE OF HEALTH OF JAPAN (THE)
Novartis Vaccines and Diagnostics Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27020120&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2065287(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Publication of CA2065287A1 publication Critical patent/CA2065287A1/fr
Application granted granted Critical
Publication of CA2065287C publication Critical patent/CA2065287C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Laminated Bodies (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne deux nouveaux isolats du virus de l'hépatite C (HCV), à savoir J1 et J7. Ces nouveaux isolats comprennent des séquences de nucléotides et d'acides aminés qui sont distincts de l'isolat HCV prototype, HCV1. Ainsi, J1 et J7 constituent de nouveaux polynucléotides et polypeptides utilisés entre autre dans les diagnostics, la production de protéines de recombinaison et le développement de vaccins.
CA002065287A 1989-09-15 1990-09-14 Isolats hvc nouveaux Expired - Lifetime CA2065287C (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US40804589A 1989-09-15 1989-09-15
US408,045 1989-09-15
US45614289A 1989-12-21 1989-12-21
US456,142 1989-12-21
PCT/US1990/005242 WO1991004262A1 (fr) 1989-09-15 1990-09-14 Nouveaux isolats du virus de l'hepatite c

Publications (2)

Publication Number Publication Date
CA2065287A1 true CA2065287A1 (fr) 1991-03-16
CA2065287C CA2065287C (fr) 1999-12-21

Family

ID=27020120

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002065287A Expired - Lifetime CA2065287C (fr) 1989-09-15 1990-09-14 Isolats hvc nouveaux

Country Status (11)

Country Link
EP (2) EP0939128A3 (fr)
JP (3) JP3156200B2 (fr)
AT (1) ATE188998T1 (fr)
CA (1) CA2065287C (fr)
DE (1) DE69033425T3 (fr)
DK (1) DK0419182T4 (fr)
ES (1) ES2141081T5 (fr)
GR (1) GR3033100T3 (fr)
IE (2) IE903363A1 (fr)
PT (1) PT95329B (fr)
WO (1) WO1991004262A1 (fr)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7166287B1 (en) 1989-12-18 2007-01-23 Glaxo Wellcome Inc. Viral agent
NO905438L (no) 1989-12-18 1991-06-19 Wellcome Found Virusmiddel.
US6596476B1 (en) * 1989-12-22 2003-07-22 Abbott Laboratories Hepatitis C assay
AU7675491A (en) * 1990-04-04 1991-10-30 Chiron Corporation Hepatitis c virus protease
JP3050395B2 (ja) * 1990-06-12 2000-06-12 国立感染症研究所長 Ｃ型肝炎ウイルス抗原ポリペプチド、その産生方法および抗体の検出方法
US5747339A (en) 1990-06-25 1998-05-05 Research Foundation For Microbial Diseases Of Osaka Non-A, non-B hepatitis virus genomic CDNA and antigen polypeptide
DE69125066T2 (de) * 1990-07-11 1997-09-25 Shionogi Seiyaku K K Trading U cDNS-Sequenz und Detektion des Hepatitis C-Virus
WO1992001714A1 (fr) * 1990-07-24 1992-02-06 Yamanouchi Pharmaceutical Co., Ltd. Antigene du virus de l'hepatite non a, non b
ATE206717T1 (de) * 1990-11-03 2001-10-15 Dade Behring Marburg Gmbh Hcv-spezifische peptide, mittel dazu und ihre verwendung
EP0485209A1 (fr) * 1990-11-08 1992-05-13 Immuno Japan Inc. Antigène relatif au virus de l'hépatite non-A non-B, systèmes de détection d'anticorps, polynucléotides et polypeptides
KR920703640A (ko) * 1990-11-29 1992-12-18 테루카츄 아리마 비a비b형 간염 바이러스 항원 단백질
US5574132A (en) * 1991-04-05 1996-11-12 Biochem Immunosystems Inc. Peptides and mixtures thereof for detecting antibodies to hepatitis C virus (HCV)
CA2065690A1 (fr) * 1991-04-10 1992-10-11 Hiroaki Okamoto Antigenes lies a l'hepatite non-a, non-b, systemes de detection, polynucleotides et polypeptides
CA2111108A1 (fr) 1991-06-10 1992-12-23 Joong Myung Cho Diagnostic de l'hepatite c et vaccins
RO117329B1 (ro) * 1991-06-24 2002-01-30 Chiron Corp Emeryville Polipeptide care contin o secventa a virusului hepatitei c
DK0529493T3 (da) * 1991-08-27 1998-08-24 Hoffmann La Roche Fremgangsmåder og reagenser til hepatitis C-detektion
CA2116764C (fr) * 1991-09-13 1999-12-07 Amy J. Weiner Compositions de polypeptides du virus de l'hepatite c immunoreactives
AU2679492A (en) * 1991-09-16 1993-04-27 Abbott Laboratories Hepatitis c assay
US6709828B1 (en) 1992-03-06 2004-03-23 N.V. Innogenetics S.A. Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them
US6667387B1 (en) 1996-09-30 2003-12-23 N.V. Innogenetics S.A. HCV core peptides
US6620414B2 (en) 1992-03-27 2003-09-16 Smithkline Beecham Biologicals (S.A.) Hepatitis vaccines containing 3-0-deacylated monophoshoryl lipid A
MA22842A1 (fr) * 1992-03-27 1993-10-01 Smithkline Beecham Biolog Procede de preparation de compositions de vaccin.
US6174868B1 (en) 1992-09-10 2001-01-16 Isis Pharmaceuticals, Inc. Compositions and methods for treatment of hepatitis C virus-associated diseases
US6433159B1 (en) 1992-09-10 2002-08-13 Isis Pharmaceuticals, Inc. Compositions and methods for treatment of Hepatitis C virus associated diseases
US6995146B2 (en) 1992-09-10 2006-02-07 Isis Pharmaceuticals, Inc. Compositions and methods for treatment of hepatitis C virus-associated diseases
US6391542B1 (en) 1992-09-10 2002-05-21 Isis Pharmaceuticals, Inc. Compositions and methods for treatment of Hepatitis C virus-associated diseases
US7255997B1 (en) 1993-04-27 2007-08-14 N.V. Innogenetics S.A. Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents
BR9405334A (pt) 1993-04-27 1999-05-25 Innogenetics Nv Novas sequências de genótipos de vírus da hepatite c e seu uso como agentes terapêuticos e diagnóstico
DE69526973T3 (de) 1994-10-21 2010-01-07 Innogenetics N.V. Sequenzen von hepatitis-c-virus genotype 7, und deren verwendung als vorbeugende, therapeutische und diagnostische mittel
EP1178116A1 (fr) * 2000-08-03 2002-02-06 Hybrigenics S.A. Acides nucléiques Sid et polypeptides sélectionnés à partir d'une souche pathogène du virus de l' hépatite ainsi que leurs applications
ATE517184T1 (de) * 2000-08-17 2011-08-15 Tripep Ab Hcv ns3/4a kodierende nukleinsäure
US7022830B2 (en) 2000-08-17 2006-04-04 Tripep Ab Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
JP2002125688A (ja) * 2000-10-30 2002-05-08 Tosoh Corp Ｃ型肝炎ウイルスの高感度検出のためのオリゴヌクレオチドおよび検出法
DE10112748A1 (de) * 2001-03-14 2002-09-19 Transmit Technologietransfer Erfindung betreffend HCV-Erkrankungen
US7196183B2 (en) 2001-08-31 2007-03-27 Innogenetics N.V. Hepatitis C virus genotype, and its use as prophylactic, therapeutic and diagnostic agent
AU2003258672B2 (en) * 2002-09-13 2008-10-30 Intercell Ag Method for isolating hepatitis C virus peptides
US8124747B2 (en) 2003-08-29 2012-02-28 Innogenetics HCV clade and prototype sequences thereof
US7473773B2 (en) 2004-01-07 2009-01-06 Third Wave Technologies, Inc. Determination of hepatitis C virus genotype
CN105697424B (zh) * 2016-01-19 2019-01-08 江苏大学 一种泵站用防旋涡装置

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2480779B2 (fr) * 1979-08-30 1986-07-18 Anvar Vecteur contenant une sequence nucleotidique de l'antigene de surface du virus de l'hepatite b et procede de fabrication d'une molecule immunogene mettant en oeuvre ce vecteur
US4870026A (en) * 1982-09-16 1989-09-26 The General Hospital Corporation Non-A, non-B. hepatitis, virus, methods of identification purification, characterization, diagnosis and immunization
US4673634A (en) * 1985-03-08 1987-06-16 The United States Of America As Represented By The Department Of Health And Human Services Purified antigen from non-A, non-B hepatitis causing factor
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4868105A (en) 1985-12-11 1989-09-19 Chiron Corporation Solution phase nucleic acid sandwich assay
US5032511A (en) * 1987-03-31 1991-07-16 Mitsubishi Kasei Corporation DNA fragments coding for antigens specific to non-A non-B hepatitis, expression vectors containing said DNA fragments, transformants and process for producing said antigens
JPH01124387A (ja) * 1987-11-10 1989-05-17 Mitsubishi Kasei Corp 非ａ非ｂ型肝炎特異抗原をコードするｄｎａを有する発現ベクター、形質転換体および該抗原の産生方法
JP2590885B2 (ja) * 1987-03-31 1997-03-12 三菱化学株式会社 Ｄｎａ断片
CA1339351C (fr) 1987-10-15 1997-08-26 Michael S. Urdea Multimeres d'acide nucleique et essais d'hybridation amplifiee d'acide nucleique
CN1049686C (zh) * 1987-11-18 2000-02-23 希龙股份有限公司 非ａ和非ｂ肝炎病毒的诊断及疫苗
JP2500880Y2 (ja) * 1988-05-02 1996-06-12 カシオ計算機株式会社 液晶表示装置
KR0185373B1 (ko) * 1989-03-17 1999-05-01 로버트 피. 블랙버언 Hcv 폴리단백질에서 유래되는 hcv 아미노산 서열 부분을 포함하는 폴리펩티드 및 그 사용
JPH0330676A (ja) * 1989-06-28 1991-02-08 Sanwa Kagaku Kenkyusho Co Ltd 非ａ非ｂ型肝炎ウイルスのｄｎａ、そのクローン及びこれらの調製法
EP0416725A3 (en) * 1989-07-14 1991-03-20 Chugai Seiyaku Kabushiki Kaisha Blood-borne non-a, non-b hepatitis specific protein, dna encoding it, and process for its production

Also Published As

Publication number Publication date
GR3033100T3 (en) 2000-08-31
PT95329A (pt) 1991-08-14
PT95329B (pt) 1998-04-30
DE69033425T3 (de) 2010-02-18
ES2141081T3 (es) 2000-03-16
JPH05506773A (ja) 1993-10-07
EP0419182A1 (fr) 1991-03-27
EP0939128A2 (fr) 1999-09-01
WO1991004262A1 (fr) 1991-04-04
JP2005143512A (ja) 2005-06-09
ES2141081T5 (es) 2009-12-11
DE69033425T2 (de) 2000-06-08
IE20020123A1 (en) 2003-05-28
DE69033425D1 (de) 2000-02-24
JPH09187285A (ja) 1997-07-22
DK0419182T3 (da) 2000-04-17
IE903363A1 (en) 1991-04-10
JP3156200B2 (ja) 2001-04-16
CA2065287C (fr) 1999-12-21
DK0419182T4 (da) 2009-11-23
EP0939128A3 (fr) 2004-06-09
EP0419182B1 (fr) 2000-01-19
EP0419182B2 (fr) 2009-07-22
ATE188998T1 (de) 2000-02-15

Similar Documents

Publication Publication Date Title
CA2065287A1 (fr) Isolats hvc nouveaux
CA2110058A1 (fr) Polypeptides du virus de l'hepatite c (vhc)
CA2032381A1 (fr) Agent viral
AU7165287A (en) DNA encoding streptavidin, streptavidin produced therefrom, fused polypeptides which include amino acid sequences present in streptavidin and uses thereof
AU2964489A (en) Dna sequences, recombinant dna molecules and processes for producing human immune interferon-like polypeptides
WO1995001442A3 (fr) Sequences de nucleotides et sequences d'acides amines du gene d'enveloppe 1 de 51 isolats du virus de l'hepatite c et utilisation de reactifs derives desdites sequences en tant que reactifs de diagnostic et vaccins
WO1992010514A3 (fr) Antigenes synthetiques pour la detection d'anticorps diriges contre le virus de l'hepatite c
WO1995012677A3 (fr) Epitopes de lymphocytes t humains immunodominants du virus de l'hepatite c
IL87647A0 (en) Dna sequences,recombinant dna molecules and processes for producing soluble t4 proteins
CA2005950A1 (fr) Arn du genome du virus de l'hepatie non a, non b, adn-c et proteine antigenique du virus
OA09116A (en) Novel protein, sequences containing the gene therefore vectors, methods of preparation and use.
GB2143830A (en) Expression of plasmodium falciparum polypeptides from cloned cdna
WO1993001210A3 (fr) Antigenes peptidiques du virus de l'hepatite c et procede pour la determination du virus de l'hepatite c
AU3406595A (en) Nucleotide and amino acid sequences of the envelope 1 and core genes of hepatitis c virus
HU910069D0 (en) Process for the production of non-a, non-b hepathitis virus genomial dna and antigene polypeptide
NZ235764A (en) Htlv-i env gp21 derived polypeptides, nucleotide sequences, vectors, hybrid polypeptides, hosts, immunoassays, and production of the polypeptides by recombinant methods
AU6358190A (en) Polypeptide vaccines against foot-and-mouth disease virus
AU3597089A (en) Method for producing nonhyperglycosylated hepatitis b virus proteins
EP0416725A3 (en) Blood-borne non-a, non-b hepatitis specific protein, dna encoding it, and process for its production
EP0311228A3 (fr) Polypeptides recombinants et leur utilisation, y compris un diagnostic pour le virus du SIDA
CA2217633A1 (fr) Genes codant des polypeptides servant de facteur de regulation de l'interferon specifique des lymphocytes (lsirf)
AU3038889A (en) Dna sequences, recombinant dna molecules and processes for producing stromal derived lymphopoietic factor-1 polypeptides
SG145521A1 (en) Synthetic antigens for the detection of antibodies to hepatitis c virus
IL109082A0 (en) Proteins, gene vectors, and methods for the preparation thereof
IE891804L (en) Nonhyperglycosylated hepatitis b virus proteins

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry